This includes EGLN1, a well described cancer gene involved in regulation of tumor hypoxia, and CDC42, an oncogene involved in cell cycle control (Chan and Giaccia, 2010; Maldonado and Dharmawardhane, 2018). This evidence concerns the gene EGLN1 and neoplasm.